These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 30615673
1. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673 [Abstract] [Full Text] [Related]
2. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576 [Abstract] [Full Text] [Related]
3. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients. Roth P, Keller A, Hoheisel JD, Codo P, Bauer AS, Backes C, Leidinger P, Meese E, Thiel E, Korfel A, Weller M. Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293 [Abstract] [Full Text] [Related]
6. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R, Maghnouj A, Zöllner H, Reinacher-Schick A, Schmiegel W, Hahn SA, Schroers R. Blood; 2011 Mar 17; 117(11):3140-6. PubMed ID: 21200023 [Abstract] [Full Text] [Related]
7. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G. Oncol Rep; 2017 Jun 17; 37(6):3543-3553. PubMed ID: 28498428 [Abstract] [Full Text] [Related]
8. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C, Zhang CD, Ma MH, Dai DQ. World J Gastroenterol; 2018 Mar 21; 24(11):1206-1215. PubMed ID: 29568201 [Abstract] [Full Text] [Related]
12. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer. Zeng Y, Wang KX, Xu H, Hong Y. J Cell Biochem; 2018 Feb 21; 119(2):1558-1566. PubMed ID: 28771797 [Abstract] [Full Text] [Related]
13. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer. Xiaoli Z, Yawei W, Lianna L, Haifeng L, Hui Z. Med Sci Monit; 2015 Dec 02; 21():3748-59. PubMed ID: 26628405 [Abstract] [Full Text] [Related]
14. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets. Sharma P, Saraya A, Sharma R. Asia Pac J Clin Oncol; 2018 Oct 02; 14(5):e289-e301. PubMed ID: 29380534 [Abstract] [Full Text] [Related]
15. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor. Gong Y, Zou B, Chen J, Ding L, Li P, Chen J, Chen J, Zhang B, Li J. Med Sci Monit; 2019 Jul 22; 25():5435-5444. PubMed ID: 31328722 [Abstract] [Full Text] [Related]
16. Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma. Zheng R, Mao W, Du Z, Zhang J, Wang M, Hu M. Biochem Biophys Res Commun; 2018 Dec 09; 507(1-4):377-382. PubMed ID: 30442364 [Abstract] [Full Text] [Related]
18. GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. Takashima Y, Hamano M, Fukai J, Iwadate Y, Kajiwara K, Kobayashi T, Hondoh H, Yamanaka R. Sci Rep; 2020 May 21; 10(1):8435. PubMed ID: 32439996 [Abstract] [Full Text] [Related]
19. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R. Int J Cancer; 2013 Apr 01; 132(7):1633-45. PubMed ID: 22987275 [Abstract] [Full Text] [Related]